Paper37366237
Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease.
Liu Q and 6 others. EMBO J, 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease. Papers, record 37366237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37366237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Parkinson Disease | Major topic |
| Animals | |
| Mice | |
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | |
| Protein Serine-Threonine Kinases | |
| RNA Stability | |
| RNA, Messenger | |
| Mutation | |
| Aminoimidazole Carboxamide | |
| Ribonucleotides |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K01 AG046366 | NIA NIH HHS | United States | K01AG046366 | PubMed and NIH | NIH RePORTER |
| R01 GM136904 | NIGMS NIH HHS | United States | R01GM136904 | PubMed and NIH | NIH RePORTER |
| R01 NS112506 | NINDS NIH HHS | United States | R01NS112506 | PubMed and NIH | NIH RePORTER |
| R01 GM136904 | NIGMS NIH HHS | United States | R01GM136904 | PubMed and NIH | NIH RePORTER |
| R01 NS112506 | NINDS NIH HHS | United States | R01NS112506 | PubMed and NIH | NIH RePORTER |
| K01 AG046366 | NIA NIH HHS | United States | K01AG046366 | PubMed and NIH | NIH RePORTER |
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28649611 | LRRK2 levels in immune cells are increased in Parkinson's disease. | NPJ Parkinsons Dis | 2017 | https://conductscience.org/library/papers/28649611 | PubMed |
| 2 | 18258746 | A Drosophila model for LRRK2-linked parkinsonism. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18258746 | PubMed |
| 3 | 33454605 | Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease. | Parkinsonism Relat Disord | 2021 | https://conductscience.org/library/papers/33454605 | PubMed |
| 4 | 21859862 | c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P bodies. | J Cell Biol | 2011 | https://conductscience.org/library/papers/21859862 | PubMed |
| 5 | 19536328 | Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. | PLoS One | 2009 | https://conductscience.org/library/papers/19536328 | PubMed |
| 6 | 34064363 | AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review. | Cells | 2021 | https://conductscience.org/library/papers/34064363 | PubMed |
| 7 | 27911006 | LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies. | Mov Disord | 2017 | https://conductscience.org/library/papers/27911006 | PubMed |
| 8 | 27658356 | Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation. | Sci Rep | 2016 | https://conductscience.org/library/papers/27658356 | PubMed |
| 9 | 23967090 | Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus. | PLoS One | 2013 | https://conductscience.org/library/papers/23967090 | PubMed |
| 10 | 20041156 | The WD40 domain is required for LRRK2 neurotoxicity. | PLoS One | 2009 | https://conductscience.org/library/papers/20041156 | PubMed |
| 11 | 34439767 | LRRK2 Targeting Strategies as Potential Treatment of Parkinson's Disease. | Biomolecules | 2021 | https://conductscience.org/library/papers/34439767 | PubMed |
| 12 | 11689683 | Yeast AMP pathway genes respond to adenine through regulated synthesis of a metabolic intermediate. | Mol Cell Biol | 2001 | https://conductscience.org/library/papers/11689683 | PubMed |
| 13 | 6150139 | An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. | Lancet | 1984 | https://conductscience.org/library/papers/6150139 | PubMed |
| 14 | 35637059 | Case report of a rare purine synthesis disorder due to 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICAR) deficiency. | Brain Dev | 2022 | https://conductscience.org/library/papers/35637059 | PubMed |
| 15 | 35675433 | Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35675433 | PubMed |
| 16 | 7744080 | 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? | Eur J Biochem | 1995 | https://conductscience.org/library/papers/7744080 | PubMed |
| 17 | 15114530 | AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC. | Am J Hum Genet | 2004 | https://conductscience.org/library/papers/15114530 | PubMed |
| 18 | 21603177 | Lipopolysaccharide animal models for Parkinson's disease. | Parkinsons Dis | 2011 | https://conductscience.org/library/papers/21603177 | PubMed |
| 19 | 32557644 | AICA-ribosiduria due to ATIC deficiency: Delineation of the phenotype with three novel cases, and long-term update on the first case. | J Inherit Metab Dis | 2020 | https://conductscience.org/library/papers/32557644 | PubMed |
| 20 | 19196961 | CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19196961 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42588185 | Alterations in Gut Microbiota and Serum Metabolome Are Associated with Postpartum Depression. | Nutrients | 2026 | https://conductscience.org/library/papers/42588185 | PubMed |
| 42477458 | Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer. | Oncogene | 2026 | https://conductscience.org/library/papers/42477458 | PubMed |
| 42470822 | Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/42470822 | PubMed |
| 41226290 | Construction of a Zebrafish Model of Cardiac Hypertrophy Caused by ATIC Gene Deletion and Preliminary Exploration of Aerobic Exercise Improvement. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226290 | PubMed |
| 41194937 | CircUBAP2(9,12) Inhibits Nasopharyngeal Carcinoma Invasion and Metastasis by Down-regulating ZEB2 through Competitive Binding to AUF1. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/41194937 | PubMed |
| 40076730 | LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson's Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076730 | PubMed |
| 39705401 | In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson's disease. | Brain | 2025 | https://conductscience.org/library/papers/39705401 | PubMed |
| 39576856 | CalDAG-GEFI acts as a guanine nucleotide exchange factor for LRRK2 to regulate LRRK2 function and neurodegeneration. | Sci Adv | 2024 | https://conductscience.org/library/papers/39576856 | PubMed |
| 39153957 | LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting. | Trends Mol Med | 2024 | https://conductscience.org/library/papers/39153957 | PubMed |
| 37697064 | Circular RNA EIF3I promotes papillary thyroid cancer progression by interacting with AUF1 to increase Cyclin D1 production. | Oncogene | 2023 | https://conductscience.org/library/papers/37697064 | PubMed |
| 37366237 | Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE-mediated mRNA decay in Parkinson's disease. | EMBO J | 2023 | https://conductscience.org/library/papers/37366237 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| LRRK2 | 120892 | PubTator's text mining | https://conductscience.org/library/genes/120892 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37366237
GET https://conductscience.org/api/papers/v1/37366237/references?page=2